Binnacle Investments’s Genmab GMAB Stock Holding History

Binnacle Investments’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.2K	Hold	39	–	–	﹤0.01%	722
2025 Q2	$806	Buy	39 +23	+144%	+$472	﹤0.01%	698
2025 Q1	$313	Buy	+16	New	+$336	﹤0.01%	751

Other funds holding GMAB

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Binnacle Investments's GMAB Position: Q3 2025 in Review

Binnacle Investments held its Genmab (GMAB) position steady in Q3 2025 at 39 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #722.

Binnacle Investments first reported a position in GMAB in Q1 2025 and has held it in 3 quarters since. 252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

Binnacle Investments held 39 shares of Genmab worth $1.2K as of Q3 2025.
Binnacle Investments left its Genmab share count unchanged in Q3 2025.
Genmab made up ﹤0.01% of Binnacle Investments's portfolio in Q3 2025, its #722 holding.
Binnacle Investments first reported a position in Genmab in Q1 2025 and has held it in 3 quarters since.
252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.